KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ginkgo Bioworks Holdings (DNA) Current Deferred Revenue (2019 - 2025)

Ginkgo Bioworks Holdings filings provide 7 years of Current Deferred Revenue readings, the most recent being $18.9 million for Q4 2025.

  • On a quarterly basis, Current Deferred Revenue fell 85.02% to $18.9 million in Q4 2025 year-over-year; TTM through Dec 2025 was $18.9 million, a 85.02% decrease, with the full-year FY2025 number at $18.9 million, down 85.02% from a year prior.
  • Current Deferred Revenue hit $18.9 million in Q4 2025 for Ginkgo Bioworks Holdings, down from $25.2 million in the prior quarter.
  • In the past five years, Current Deferred Revenue ranged from a high of $222.6 million in Q4 2022 to a low of $18.9 million in Q4 2025.
  • Median Current Deferred Revenue over the past 5 years was $37.2 million (2022), compared with a mean of $77.8 million.
  • Biggest five-year swings in Current Deferred Revenue: soared 94500.0% in 2021 and later plummeted 85.02% in 2025.
  • Ginkgo Bioworks Holdings' Current Deferred Revenue stood at $189.2 million in 2021, then increased by 17.65% to $222.6 million in 2022, then dropped by 9.03% to $202.5 million in 2023, then crashed by 37.53% to $126.5 million in 2024, then plummeted by 85.02% to $18.9 million in 2025.
  • The last three reported values for Current Deferred Revenue were $18.9 million (Q4 2025), $25.2 million (Q3 2025), and $28.3 million (Q2 2025) per Business Quant data.